Patients often have trouble finding the information they need to make the right choices for themselves and for their families. Information about medical research studies isn’t hidden, but it isn’t always presented in terms that patients understand. What are the inclusion criteria for clinical trials? What are the potential risks? If everything goes well, what positive outcomes can patients reasonably expect?
Even patients ready to participate can have trouble finding a clinical trial near them—and figuring out if they qualify to take part.
As a healthcare provider, you can help your patients navigate the clinical trial space and find the best options for their unique situation.
Just as important as participating in a clinical trial is the health benefits in making this data and information available to health care providers, researchers, patients and the general public. Thus, we have adopted national and international principles and standards regarding the sharing and publication of clinical trials data and information, including the PhRMA-EFPIA Principles for Responsible Clinical Trial Data Sharing.
Informed consent given by study participants
Commercially confidential information and intellectual property
The role of regulatory authorities in making risk-benefit decisions that determine access to our products
The rights of scientists to undertake scientifically valid research that will advance public health interests
We will review and, where appropriate, update our approach to data and information sharing in response to feedback received and changing principles and standards governing this topic in the future.
AbbVie has certified that we have established policies and procedures that meet our data sharing commitments with PhRMA and EFPIA. In addition, AbbVie conducts audits of compliance to ensure we are meeting those principles and standards.